New Food and Drug Administration Commissioner Should Reform the Center for Tobacco Products

In 2025, the CTP reduced the backlog of premarket tobacco product applications (PMTAs) by about 70 percent. This year, the CTP is already accelerating PMTA reviews further and allowing some leeway for products under review but not yet officially authorized. This is great progress, but much more can be made.